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ABSTRACT
In recent years, increasingly augmentation of health data, such
as patient Electronic Health Records (EHR), are becoming readily
available. This provides an unprecedented opportunity for knowl-
edge discovery and data mining algorithms to dig insights from
them, which can, later on, be helpful to the improvement of the qual-
ity of care delivery. Predictive modeling of clinical risk, including
in-hospital mortality, hospital readmission, chronic disease onset,
condition exacerbation, etc., from patient EHR, is one of the health
data analytic problems that attract most of the interests. The reason
is not only because the problem is important in clinical settings,
but also there are challenges working with EHR such as sparsity,
irregularity, temporality, etc. Different from applications in other
domains such as computer vision and natural language processing,
the labeled data samples in medicine (patients) are relatively lim-
ited, which creates lots of troubles for effective predictive model
learning, especially for complicated models such as deep learning.
In this paper, we propose MetaPred, a meta-learning for clinical
risk prediction from longitudinal patient EHRs. In particular, in or-
der to predict the target risk where there are limited data samples,
we train a meta-learner from a set of related risk prediction tasks
which learns how a good predictor is learned. The meta-learned
can then be directly used in target risk prediction, and the limited
available samples can be used for further fine-tuning the model
performance. The effectiveness of MetaPred is tested on a real pa-
tient EHR repository from Oregon Health & Science University. We
are able to demonstrate that with Convolutional Neural Network
(CNN) and Recurrent Neural Network (RNN) as base predictors,
MetaPred can achieve much better performance for predicting tar-
get risk with low resources comparing with the predictor trained
on the limited samples available for this risk.
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1 INTRODUCTION
The recent years have witnessed a surge of interests in healthcare
analytics with longitudinal patient Electronic Health Records (EHR)
[21]. Predictive modeling of clinical risk, such as mortality [37, 39],
hospital readmission [6, 35], onset of chronic disease [8], condition
exacerbation [22], etc., has been one of the most popular research
topics. This is mainly because 1) accurate clinical risk prediction
models can help the clinical decisionmakers to identify the potential
risk at its early stage, therefore appropriate actions can be taken
in time to provide the patient with better care; 2) there are many
challenges on analyzing patient EHR, such as sequentiality, sparsity,
noisiness, irregularity, etc. [43]. Many computational algorithms
have been developed to overcome these challenges, including both
conventional approaches [6] and deep learning models [8].
One important characteristic that makes those healthcare prob-
lems different from the applications in other domains, such as
computer vision [29], speech analysis [12] and natural language
processing [44], is that the number of the available sample data set
is typically limited, and typically it is very expensive and sometimes
even impossible for obtaining new samples. For example, for the
case of individualized patient risk prediction, where the goal is to
predict a certain clinical risk for each patient, each data sample
corresponds to a patient. There are in total just 7.5 billion people
all over the world, and the number will be far less if we focus on
a specific disease condition. These patients are also distributed in
different continents, different states, different cities, and different
hospitals. The reality is that we only have a small number of pa-
tients available in a specific EHR corpus for training a risk prediction
model. Moreover, the clinical risks we focus on are extraordinarily
complicated. For the majority of the deadly diseases, we are still not
clear about their underlying biological mechanisms and thus the
potential treatment strategies. This means that, in order to learn
accurate clinical risk prediction models, we need to make sufficient
use the limited patient samples, and effectively leverage available
knowledge about the clinical risk as well as predictive models.
Recently, transfer learning [31] has been demonstrated as an
effective mechanism to achieve good performance in learning with
limited samples in medical problems. For example, in computer
vision, Inception-V3 [38] is a powerful model for image analysis.
Google has released the model parameters trained on the huge Im-
ageNet data set [11]. Esteva et al. [14] adopted such a model as the
starting point, and leveraged a locally collected 130K skin images
to fine-tune the model to discriminate benign vs. malignant skin
lesions. They achieved satisfactory classification performance that
is comparable to the performance of well-trained dermatologists.
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Similar strategies have also achieved good performance in other
medical problems with different types of medical images [18, 23]. In
addition to computer vision, powerful natural language processing
models such as transformer [41] and BERT [13] with parameters
trained on general natural language data, have also been fine-tuned
to analyze unstructured medical data [30]. Because these models
are pre-trained on general data, they can only encode some general
knowledge, which is not specific to medical problems. Moreover,
such models are only available with certain complicated architec-
tures with a huge amount of general training data. It is difficult to
judge how and why such a mechanism will be effective in which
clinical scenarios.
In this paper, we propose MetaPred, a meta-learning framework
for low-resource predictive modeling with patient EHRs. Meta-
learning [33, 40] is a recent trend in machine learning aiming at
learning to learn. By low-resource, we mean that only limited EHRs
can be used for the target clinical risk, which is insufficient to
train a good predictor by seen samples of the task themselves.
For this scenario, we develop a model agnostic gradient descent
framework to train a meta-learner on a set of prediction tasks
where the target clinical risks are highly relevant. For these tasks,
we choose one of them as the simulated target and the rest as
sources. The parameters of the predictive model will be updated
through a step-by-step sequential optimization process. In each
step, an episode of data will be sampled from the sources and the
simulated target to support the updating on model parameters. To
compensate for the optimization-level fast adaptation, an objective-
level adaptation is also proposed. We validate the effectiveness
of MetaPred on a large-scale real-world patient EHR corpus with a
set of cognition related disorders as the clinical risks to be predicted,
and Convolutional Neural Networks (CNN) as well as Long-Short
Term Memory (LSTM) are applied as the predictors because of their
popularity in EHR-based analysis. Additionally, we demonstrate
that if we use EHRs in target domains to fine-tune the learned
model, the prediction performance can be further improved.
The rest of the paper is organized as follows: the problem setup
is presented in Section 2; the proposed framework MetaPred is
introduced in Section 3; experimental results are shown in Section
4 and related works are summarized in Section 5; finally, conclusion
reaches at Section 6.
2 PROBLEM SETUP
In order to introduce our framework, we provide a graphical illus-
tration in Figure 1. Suppose the target task is the prediction of the
onset risk of Alzheimer’s Disease where we do not have enough
training patient samples, and we want to transfer knowledge from
other related disease domains with sufficient labels such as Mild
Cognitive Impairment (MCI) or Dementia. However, traditional
transfer learning would be also constrained by the small number
of training samples, especially for those with complicated neural
networks. Consequently, we take advantage of meta-learning by
setting a simulated target domain for learning to transfer. Though
applying meta-learning settings on the top of low-resource medical
records for disease prediction seems intuitive, how to set up the
problem is crucial.
Figure 1: Illustration of the proposed learning procedure. In
this example, our goal is to predict the risks of Alzheimer’s
disease with few labeled patients, which give rise to a low-
resource classification. The idea is to take advantage of la-
beled patients from other relevant high-resource domains
and design the learning to transfer workflow with sources
and a simulated target via meta-learning.
More formally, we consider multiple related disease conditions as
the set of source domainsS1, · · · ,SK and a target domain T 0. This
leads to K + 1 domains in total. In each domain, we can construct
a training data set including the EHRs of both case (positive) and
control (negative) patients. We use the data collection {(X, y)}i , i =
0, 1, · · · ,K to denote the features and labels of the patients in these
K+1 domains. Our goal is to learn a predictivemodel f for the target
domain T 0. In the following we use Θ to denote the parameters
of f . Because only a limited number of samples are available in
T 0, we hope to leverage the data from those source domains, i.e.,
f = (DS ,X;Θ), where DS denotes the collection of data samples
in the source domains. From the perspective of domain adaptation
[4], the problem can be reduced to the design and optimization of
model f in an appropriate form of DS .
In this section we will mainly introduce how to utilize the source
domain data DS in our MetaPred framework. The details on the
design of f will be introduced in the next section. In general, su-
pervised meta-learning provides models trained by data episodes
{Di } which is composed of multiple samples. Each Di is usually
split into two parts according to their labels. We further refer to
the domain where the testing data are from the simulated target
domain DTs , and it is still one of the source domains. Followed
previous work [15, 32], we called the training procedure based on
this split as meta-train, and the testing procedure as meta-test.
In summary, the proposed MetaPred framework illustrated in
Figure 1 consists of four steps: (1) constructing episodes by sampling
from the source domains and the simulated target domain; (2) learn
the parameters of predictors in an episode-by-episode manner; (3)
fine-tuning the model parameters on the genuine target domain;
(4) predicting the target clinical risk.
Figure 2: The overview of MetaPredworkflow. Depi is an episode randomly sampled. {Si }K−1i=1 denotes source domains andT s denotes the simulated target domain. The two gradient update loops of meta-training process are illustrated. The yellow
colored blocks and arrows are associated with Learner, while the blue ones are associated with MetaLearner. (“Target loss” is
used here instead of “Simulated Target loss” for simplicity.)
3 THE METAPRED FRAMEWORK
The model-agnostic meta-learning strategy [15] serves as the back-
bone of our MetaPred framework. In particular, our goal is to learn
a risk predictor on the target domain. In order to achieve that, we
first perform model agnostic meta-learning on the source domains,
where the model parameters are learned through
Θ∗ = Learner(T s ;MetaLearner(S1, · · · ,SK−1)) (1)
where for each data episode, the model parameters are first adjusted
through gradient descents on the objective loss measure on the
training data from the source domains (MetaLearner), and then
they will be further adjusted on the simulated target domain T s
(Learner). In the following, we will introduce the learning process
in detail, where the risk prediction model is assumed to be either
CNN or LTSM. First we provide basic neural network prediction
models as the options for Learner. Then we introduce the entire
parameter learning procedure of the proposed MetaPred, including
optimization-level adaptation and objective-level adaptation.
3.1 Risk Prediction Models
The EHR can be represented by sequences with multiple visits oc-
curring at different time points for each patient. At each visit, the
records can be depicted by a binary vector xt ∈ {0, 1} |C | , where t
denotes the time point. The values of 1 indicate the corresponding
medical event occurs at t , and 0 otherwise. C is the vocabulary of
medical events, and |C| is its cardinality. Thus input of the predic-
tive models can be denoted as a multivariate time series matrix
Xi = {xti }Tit=1, where i is the patient index and Ti is the number of
visits for patient i . The risk prediction model is trained to find a
transformation mapping from input time series matrix Xi to the
target disease label yi ∈ {0, 1}2. This makes the problem a sequence
classification problem.
CNN-based Sequence Learning. There are three basic modules
in our CNN based structure: embedding Layer, convolutional layer
and multi-layer perceptron (MLP). Similar to natural language pro-
cessing tasks [24], 1-dimensional convolution operators are used
to discover the data patterns along the temporal dimension t . Be-
cause the values of medical records at the visits are distributed
in a discrete space, which is sparse and high-dimensional. It is
necessary to place an embedding layer before CNN, to obtain a
more compact continuous space for patient representation. The
learnable parameters of the embedding layer are a weight matrix
Wemb ∈ Rd×|C | and a bias vector bemb ∈ Rd , where d is a dimen-
sion of the continuous space. The input vector at each visit xt is
mapped.
The 1-dimensional convolution network employs multiple filter
matrices with one of their dimension fixed as the same as hidden
dimension d , which can be denoted asWconv ∈ Rl×d . The other
filter dimension l denotes the size of a filter. A max pooling layer is
added after the convolution operation to get the most significant
dimensions formed into a vector representation for each patient.
Finally, three MLP layers are used to produce the risk probabilities
as a prediction yˆi for the patient i . To sum, all of the weight matrices,
as well as bias vectors in our three basicmodules, make up thewhole
collection of parameter Θ, which is optimized through feeding the
network patients’ data D = {(Xi , yi )}.
LSTM-based Sequence Learning. Recurrent Neural Networks
are frequently adopted as a predictive model with great promise
in many sequence learning tasks. As for EHRs, RNN can in prin-
ciple map from the sequential medical records of previous inputs
that “memory” information that has been processed by the model
previously. A standard LSTM model [19] is used to replace the con-
volutional layer in the CNN architecture we just introduced. LSTM
weights, which are also parts of Θ, can be summarized into two
mapping matrix as Wh ∈ Rd×4d and Wx ∈ Rd×4d . They are in
charge of gates (input, forget, output) controlling as well as cell
state updating. We keep the same network structures of the embed-
ding layer and MLPs to make CNN and LSTM comparable for each
other.
Learner. With the learned parameter Θ, the prediction probability
of an input matrix Xi is computed by yˆi = f (Xi ;Θ). The neural
networks can be optimized by minimizing the following objective
with a cross-entropy:
L(Θ) = − 1
N
N∑
i=1
(
(yi )T log (yˆi ) + (1 − yi )T log (1 − yˆi )
)
(2)
where N denotes the patient number in the training data. Similarly,
the loss functions for source and target domains have the same
formulation with Eq. (2), which are denoted as LS and LTs .
3.2 MetaPred Architecture
Optimization-Level Adaptation. In general, meta-learning aims
to optimize the objective over a variety of learning tasks T which
are associated with the corresponding datasets DT . The training
episodes Depi are generated by a data distribution p(DT ). Then
the learning procedure of parameter Θ is defined as:
Θ∗ = argmin
Θ
EmEDmepi∼p(DT )LΘ(DT ) (3)
wherem episodes of training samples are used in the optimization.
LΘ is the loss function that might take different formulations de-
pending on the different strategies to design a meta-learner. As it is
claimed in meta-learning, the models should be capable of tackling
the unseen tasks during testing stages. In order to achieve this
goal, the loss function for one episode can be further defined as the
following form:
LΘ = 1|Dteepi |
∑
(Xi ,yi )∈Dteepi
LΘ
(
(Xi , yi );Dtrepi
)
(4)
where Dtrepi and Dteepi are the two parts of a sample set that
simulated training and testing in each episode as we introduced
previously. It is worth to note that Eq. (4) is a loss decided by the
prediction qualities of samples in Dteepi . The model-agnostic meta-
learning (MAML) [15] provides us a parameter initialization scheme
for Θ in Eq. (4) by taking full advantage of Dtrepi . It assumes that
there should be some internal representations are more transfer-
able than others, which could be discovered by an inner learning
procedure using Dtrepi . Based on the essential idea, we show the
underlying mechanism of model-agnostic meta-learning fits the
problem of transferring knowledge from source domains to a low-
resource target domain very well, which can be used in solving the
risk prediction problem of several underdiagnosed diseases.
Figure 2 illustrates the architecture of the proposed MetaPred.
The general meta-learning algorithms generate episodes over task
distributions and shuffle the tasks to make each task could be a
part of Dtrepi or Dteepi . Instead, we define the two disjoint parts of
the episode as source domains and a target domain to satisfy a
transfer learning setting. To construct a single episode Depi in the
meta-training process, we sample data via {(XSi , ySi )} ∼ p(DSi )
and {(XTs , yTs )} ∼ p(DTs ) respectively. In order to optimize Θ
that can quickly adapt to the held-out samples in target domain, the
inner learning procedure should be pushed forward by the supervise
information of the source samples. To meet this requirement, the
following gradient update occurs:
Θ′ = Θ − α∇Θ
K−1∑
i
LSi (5)
where LSi , i = 1, · · · ,K − 1 are loss functions of source domains.
α is a hyperparameter controlling the update rate. The source loss
is computed by LSi = L(ySi , f (XSi ,Θ). From Eq. (5) we can
observe that it is a standard form gradient descent optimization.
In practice, we will repeat this process k times, then output the Θ′
as an initial parameter for the simulated target domain. The inner
learning can be view as an Inner-Loop which is shown in Figure 2.
Once we set Θ = Θ′ before the update step of the simulated
target domain, the minimize problem defined by the loss given in
Eq. (4) becomes:
min
Θ
LTs (fΘ′) = min
Θ
∑
DTsepi∼p(DTs )
L (yTs , f (XTs ,Θ′)) (6)
where DTs = {(XTs , yTs )}. Given the loss form of LTs in the
simulated target domain, it is computed by the output parameter
Θ′ obtain via inner gradient update in Eq. (5). Then, the meta-
optimization using DTs is performed with:
Θ = Θ − β∇ΘLTs (fΘ′ ) (7)
where β is the meta-learning rate. Hence, the simulated target
loss involves an Outer-Loop for gradient updating. Compared to
the standard gradient updating in Eq. (5), the gradient-like term
in Eq. (7) essentially resorts to a gradient through a gradient that
can be named as meta-gradient. Accordingly, the entire learning
procedure can be viewed as: iteratively transfer the parameter Θ
learned from source domains through utilizing it as the initialization
of the parameter that needs to be updated in the simulated target
domain.
To build end-to-end risk prediction models with the model-
agnostic gradient updating, we use the deep neural network struc-
tures that are trained using medical records X and diagnosis results
y described in Section 3.1. The objectives for both source and sim-
ulated target are set as cross-entropy introduced in Eq. (2). One
interesting point is that all the parameters of source domains and
simulated target domains are tied, with different stages to update.
The colors in Figure 2 provides an indication about the aforemen-
tioned two kinds of gradient pass.
Objective-Level Adaptation. While MAML provides an effective
transferable parameter learning scheme for disease risk prediction
in the low-resource situation, it cannot ensure sufficiently transfer-
ring the critical knowledge from the source domain. On the one
hand, meta-learning generally encourages that the simulated target
task could be randomly generated, and their model could be adapted
to a large or infinite number of tasks [15, 34, 42]. Different from
these works, transfer learning often requires to capture domain
shifts. To do so, the simulated target that is used in learning to
transfer cannot be randomly sampled.
On the other hand, the task distribution is a common decisive
factor of the success for meta-learning. In other words, the dis-
tributions of the investigated source and target domains should
Algorithm 1 MetaPred Training
Require: Source domains Si ; Simulated target domain T s ;
Require: Hyperparameters α , β, µ;
1: Initialize model parameter Θ randomly
2: while Outer-Loop not done do
3: Sample batch of episodes {Depi } from DSi and DTs
4: while Inner-Loop not done do
5: {(XSi , ySi )}K−1i=1 , {(XTs , yTs )} = {Depi }
6: Compute LSi = L(ySi , f (XSi ,Θ)), i = 1, · · · ,K − 1
7: Parameter fast adaption with gradient descent:
8: Θ′ = Θ − α∇Θ∑K−1i LSi
9: end for
10: Compute LTs = L(yTs , f (XTs ,Θ′))
11: Update Θ = Θ − β∇Θ(LTs + µ
∑K−1
i LSi ) using Adam
12: end while
not be too diverse. In real-world healthcare scenario, however, pa-
tients who suffering difference diseases might have medical records
at various visits with heterogeneity. In this case, it is difficult to
meta-learn during optimization loops. To alleviate this problem,
we propose to enhance some guarantee from the objective-level in
predictive modeling so that the scarcity of the fast adaptation in
the optimization-level can be compensated. In particular, we pro-
pose to improve the objective by incorporating supervision from
source domains. The final objective of MetaPred is given in the
mathematical form as:
LT (fΘ′ ) = LTs (fΘ′ ) + µ
K−1∑
i
LSi (fΘ)
=
∑
DTsepi
L (yTs , f (XTs , Θ′)) + µ K−1∑
i
∑
DSiepi
L (ySi , f (XSi , Θ)) (8)
where {(XSi , ySi )}K−1i=1 is a collection of medical records matrix
and label vectors of source domains. DT sepi and DS
i
epi are samples
from the source domain and the simulated target domain in episode
Depi , respectively. Hyperparameter µ balances the contributions
of the sources and simulated target in the meta-learn process. Note
that the parameter of source loss is Θ but not Θ′, as there is no
need to conduct fast adaptation for source domain. Now the newly
designed meta-gradient is updated by the following equation:
Θ = Θ − β∇Θ(LTs + µ
K−1∑
i
LSi ) (9)
So far the main architecture of MetaPred is introduced. With the
incorporated source loss on the basis of general meta-learning, our
parameter learning process need to be redefined as:
Θ∗ = Learner
(
T s , {Si }K−1i ;MetaLearner({Si }K−1i )
)
(10)
The Algorithm 1 and Algorithm 2 are outlines of meta-training
and meta-testing of the MetaPred framework. Similar to meta-
training, episodes of the test set are consist of samples from the
source domain and genuine target domain. The procedure in meta-
test shows how to get a risk prediction for the given low-resource
Algorithm 2 MetaPred Testing
Require: Source domains Si ; target domain T 0;
Require: Learned parameter Θ;
1: Sample from DSi to construct testing episodes {Depi }
2: {(XSi , ySi )}K−1i=1 , {(XT0 , yT0 )} = {Depi }
3: Compute LSi = L(ySi , f (XSi ,Θ)), i = 1, · · · ,K − 1
4: Parameter fast adaption with gradient descent:
5: Θ′ = Θ − α∇Θ∑K−1i LSi
6: Evaluate predicted results of Learner({(XT0 , yT0 )};Θ′)
Table 1: Statistics of datasets with disease domains.
Domain Case Control # of visit Ave. # of visit
MCI 1,965 4,388 161,773 22.24
Alzheimer’s 1,165 4,628 136,197 20.73
Parkinson’s 1,348 3,588 105,053 20.01
Dementia 3,438 1,591 98,187 18.06
Amnesia 2,974 4,215 180,091 21.60
disease by a few gradient steps. The test set of the target disease
domain is used to construct the meta-test episodes for the model
evaluation. Since MetaPred is model-agnostic, the gradient updat-
ing scheme can be easily extended to more sophisticated neural
networks including various attention mechanisms or gates with
prior medical knowledge [3, 7].
4 EXPERIMENTS
4.1 Dataset
In this section, experimental results on a real-world EHR dataset
are reported. The data warehouse we used in experiments is the
research data warehouse (RDW) fromOregon Health & Science Uni-
versity (OHSU) Hospital. The data warehouse which contains the
EHR of over 2.5 million patients with more than 20 million patient
encounters, is mined by Oregon Clinical and Translational Research
Center (OCTRI). For certain conditions, we may not have sufficient
patients for training and testing. In our study, we selected the con-
ditions including more than 1, 000 cases (MCI, Alzheimer’s disease,
Parkinson’s disease, Dementia, and Amnesia) as the different tasks
in the multi-domain setting. For each domain, controls are patients
suffering other cognitive disorders, which makes the classification
tasks difficult and meaningful in practice. Also, Dementia and Am-
nesia are used as source domains, while the more challenging tasks
MCI, Alzheimer, Parkinson are set as target domains.
We matched the case and controls by requiring their age differ-
ence within a 5-year range so that the age distributions between
the case group and control group are consistent. For each patient,
we set a 2-year observation window to collect the training data, and
the prediction window is set to half a year (i.e., we are predicting
after half a year the onset risk of those conditions). In our exper-
iments, only patient diagnoses histories are used, which include
10,989 distinct ICD-9 codes in total. We further mapped them to
their first three digits, which ends up with 1,016 ICD-9 group codes.
The data statistics are summarized in Table 1.
Table 2: Performance on the disease classification tasks. The simulated target domain for three mainly investigated diseases
are set as Alzheimer ∼ MCI, MCI ∼ Alzheimer, and MCI ∼ Parkinson (A is a simulated target and B is a target if A ∼ B).
Training Data Model
MCI Alzheimer’s Disease Parkinson’s Disease
AUCROC F1 Score AUCROC F1 Score AUCROC F1 Score
Fully Supervised
LR 0.5861 (.01) 0.3813 (.02) 0.5369 (.01) 0.2216 (.02) 0.7504 (.01) 0.6391 (.02)
kNN 0.6106 (.01) 0.4540 (.01) 0.6713 (.02) 0.4686 (.03) 0.7599 (.01) 0.6403 (.01)
RF 0.6564 (.01) 0.4998 (.01) 0.6300 (.02) 0.4111 (.04) 0.7750 (.01) 0.6898 (.02)
MLP 0.6515 (.01) 0.5077 (.01) 0.6639 (.02) 0.4901 (.03) 0.7958 (.02) 0.7027 (.01)
CNN 0.6999 (.01) 0.5816 (.02) 0.6755 (.03) 0.4935 (.04) 0.7980 (.01) 0.7265 (.02)
LSTM 0.6874 (.01) 0.5666 (.02) 0.6902 (.01) 0.5316 (.02) 0.8041 (.02) 0.7241 (.02)
Low-Resource
Meta-CNN 0.7624 (.02) 0.6992 (.02) 0.7682 (.01) 0.6434 (.03) 0.7604 (.02) 0.6737 (.03)
Meta-LSTM 0.7876 (.02) 0.7225 (.02) 0.7464 (.02) 0.6170 (.03) 0.7532 (.02) 0.6753 (.03)
Fully Fine-Tuned
Meta-CNN 0.8470 (.01) 0.7888 (.02) 0.8461 (.01) 0.7375 (.01) 0.8343 (.01) 0.7406 (.01)
Meta-LSTM 0.8477 (.01) 0.7963 (.02) 0.8232 (.01) 0.7364 (.01) 0.8172 (.01) 0.7291 (.02)
4.2 Experimental Setup
Metric & Models for comparison. In our experiments, we take
the AUROC (area under receiver operating characteristic curve)
and F1 Score as the prediction performance measures. We compare
the performance of the MetaPred framework with the following
approaches established on the target task.
Supervised classification models.Three traditional classificationmod-
els without considering any sequential EHR information, including
Logistic Regression (LR), k-Nearest Neighbors algorithm (k-NN),
and Random Forest (RF), are implemented as baselines, where
the patient vectors are formed by counting the frequencies of
specific diagnosis codes during the observation window. Deep
learning models, including Embedding Layer-MLP and Embedding
Layer-CNN/LSTM-MLP architectures are implemented as baselines.
Fine-tuned models. For the adaptation to a target domain, training
data of target domains can be used in fine-tuning an established
meta-learning model based on sources. Among the basic blocks of
the built networks, we consider fine-tuning MLP layers meanwhile
freeze the embedding layer and CNN/LSTM blocks. Therefore, MLP
can be viewed as a task-specific architecture leaned based on the
corresponding target.
Low-Resources models. Since there are no prior efforts focusing on
the critical problem of low-resource medical records. We propose
two variants of MetaPred to verify its feasibility and effectiveness.
Depends on the choice of modules for sequencing learning, we build
Meta-CNN and Meta-LSTM to predict disease risks with limited tar-
get samples. Specifically, patients in the true target domain are not
used in generating the episodes during meta-training, which makes
our setup satisfying the meta-learning tasks. Then a small part of
the training target set is employed to fine-tune the learned models.
We keep this ratio as 20% to simulate low-resource situations.
To show the superior of the parameter transferable ability, we
compare the performance of MetaPred with a basic parameter
transfer learning algorithm [28, 31], which solves the following
posterior maximization problem:
argmax
Θ
Σ(X,y)∈DT logp(y |X,Θ) − γ ∥Θ − Θ0∥ (11)
where Θ0 is an initial parameter setting for the target domain.
The norm term gives a prior distribution of parameters and con-
straints that the learned model for target task should not deviate too
much from the one learned from source tasks. The transfer learn-
ing models are named TransLearn. In addition, multitask learning
methods [5, 10] are employed to be another comparison in the
limited-resource scenario. In particular, we fix the bottom layers
and use domain-specific MLP in the multitask baseline MultiLearn.
For a fair comparison, the above approaches are all evaluated by
held-out test sets of the target domains.
Implementation Details and Model Selection. For all above al-
gorithms, 20% patients of the labeled patients are used as a test set
for the three main tasks and train models on the remaining 80%.
We randomly split patients with this ratio for target domain and
run experiments five times. The average performance is reported.
The deep learning approaches including the proposed MetaPred
are implemented with Tensorflow. The network architectures of
CNN and LSTM, as well as other hyperparameters are tuned by the
5-fold cross-validation. In detail, The hidden dimensions of embed-
ding layer and 2 fully connected layers are set as demb = 256 and
dmlp = 128. The vocabulary size is consistent with ICD-9 diagnosis
codes, which is grouped as dvol = 1017 including 1 padding index.
The sequence length is chosen according to the average number
of visit per patient in Table 1. Batch normalization [20] and layer
normalization [2] are employed based on CNN and LSTM respec-
tively. We keep the same network configurations for single task
models and meta-learning models. We use Adam [25] optimizer
with a batch size of 32 episodes to compute the meta-gradient. In
each episode, the number of patients used for each domain is set
at 8. The proposed MetaPred is trained on machines with NVIDIA
TESLA V100 GPUs. The source code of MetaPred is publicly avail-
able at https://github.com/sheryl-ai/MetaPred.
(a) MCI (b) Alzheimer’s Disease (c) Parkinson’s Disease
Figure 3: Results with respect to different levels of labeled data resource used in fine-tuning for target domains.
4.3 Performance Evaluation
Performance on Clinical Risk Prediction. The performance of
compared approaches on three mainly investigated risk prediction
tasks are presented in Table 2. According to how many training
data used in the target domain, there are full supervised baselines
including traditional classifiers and deep predictive models, our
proposed methods Meta-CNN/LSTM partially using the training
data in fine-tuning, as well as the fully fine-tuned MetaPredmodels.
The medical knowledge about cognitive diseases suggests us that
MCI and Alzheimer are fairly difficult to be distinguished with
other relevant disorders. Nevertheless, the symptoms of Parkinson’s
Disease sometimes are obvious to be recognized, which makes it a
relatively easier task.
From Table 2 we can observe that results obtained by LR, kNN,
RF, and neural networks cannot achieve a satisfying classification
performance through merely modeling the target tasks of MCI
and Alzheimer. Our method Meta-CNN/LSTM perform better than
single task models even with only 20% labeled target samples in fine-
tuning. TheAUC of MetaPred reaches at 0.7876±.02 and 0.7682±.01
while their corresponding single-task versions only have 0.6874 ±
.01 and 0.6755 ± .03. As for Parkinson, because of the insufficient
labeled data, the results of low-resource cannot beat CNN/LSTM.
It also indicates that the domain shift exists in real-world disease
predictions. Under the fully fine-tuned setting, the labels of targets
are the same as the fully supervised setting. MetaPred achieves
significant improvements on all the three classification tasks in
terms of AUC and F1 Score.
Comparisons at the different resource levels. In order to show
the superiority of MetaPred in the transferability with multiple
domains, transfer learning and multitask learning methods are
used in comparisons. Figure 3 shows F1 Score results giving la-
beled targets samples at the percentage {20%, 40%, 60%, 80%, 100%}
of the available training data in target domain. For the transfer
learning model TransLearn in Eq.(11), we tried various tasks as
source domains and finally used the setting Alzheimer ∼ MCI,
MCI ∼ Alzheimer, and MCI ∼ Parkinson where the best per-
formance achieved. Meanwhile, MultiLearn models are compared
with the same level of supervision in the three given target tasks.
We randomly picked the labeled data from training set five times,
and the mean and variance are presented in Figure 3. We adopt CNN
as the predictive model for the compared methods here. As we can
(a) Meta-CNN vs. MAML-CNN (b) Meta-LSTM vs. MAML-LSTM
Figure 4: Comparison between MetaPred andMAML in terms
of performance curve along with the learning procedures
(Results on Alzheimer’s Disease).
see, MetaPred outperforms TransLearn and MultiLearn on all of
the tasks. The gap is large for MCI and Alzheimer especially when
the labeled data are low. The TransLearnmethod can also perform
well on the Parkinson task due to their homogeneity in several
symptoms. Overall, the fast adaptation in both optimization-level
and objective-level leads to more robust prediction results under
low-resource circumstances.
MetaPred vs. MAML. To demonstrate the effectiveness of the pro-
posed MetaPred learning procedure and to empirically certify the
rationality of objective-level adaptation, we compare it with the
state-of-the-art meta-learning algorithm MAML [15]. Experimen-
tal results of this comparison are shown in Figure 4. To simulate
the low-resource scenario, both MetaPred and MAML use all the
available samples from sources and a simulated target for meta-
train and 20% labeled target patients in fine-tuning. To make the
comparison fair, we use the same sets of labeled patients in the
evaluation. The experiments are repeated five times, and the aver-
aged performance with the confidence interval set as 95% are given.
Figure 4 gives results in terms of AUC and F1 Score for Alzheimer’s
Disease classification using both CNN and LSTM as the base predic-
tive models. Along with the training iterations, the metric scores
of both MetaPred and MAML converge to a stable value, suggest-
ing the stability of the meta-optimization. Our method MetaPred
achieve better performance in the disease risk prediction tasks by
incorporating the supervised information of source domain.
(a) MCI (b) Alzheimer’s Disease (c) Parkinson’s Disease
Figure 5: Results with respect to different combinations of source disease domains. The best results among different source
domains are reported for the transfer learning method (Compared methods are all under the low-resource setting).
Figure 6: Visualization using a t-SNE plot of patient repre-
sentation in a 2 dimensional space. Node denotes patient suf-
fering cognition disorders we studied. Color indicates the as-
sociated domains.
Impact of Source Domain. In Figure 5, we vary the source do-
mains as {DM, PD, AM}, {DM, PD, AM}, and {AD, DM, AM}1 and
show the F1 Score results for MCI, Alzheimer, and Parkinson, re-
spectively. TransLearn is used as a baseline here. Similarly, the sim-
ulated targets are set as Alzheimer ∼ MCI, MCI ∼ Alzheimer,
and MCI ∼ Parkinson. Once the simulated target is fixed, we
first evaluate the source domain one-by-one, then feed all of them
through episode generator in meta-train. Compared to TransLearn,
the variants of MetaPred generally performs better on the basis of
both CNN and LSTM. Intuitively, using samples from more source
domains leads to a more comprehensive representation space and
thus a better prediction result on targets, which is verified by Fig-
ure 5 very well. Besides, source domains have an influence on the
performance largely, especially forMCI andAlzheimer. For example,
the largest gap of F1 Score could be close to 0.25 in MCI prediction.
The analysis helps us to choose the source domain according to
1AD, PD, DM, AM are abbreviations of Alzheimer’s Disease, Parkinson’s Disease,
Dementia, and Amnesia, respectively.
their performance on the target predictions. That is, Amnesia al-
ways benefits more as a source domain whereas Parkinson benefits
less compared to other sources.
Visualization. Figure 6 provides the visualization results. The rep-
resentations learned before the last MLP layer of MetaPred can be
extracted as high-level features for patients. The feature dimension
is 128 as we aforementioned. During the representation learning, we
hold-out 518 cases from each domain, and build a MetaPred upon
the rest of the data. Then, the held-out patients are clustered via
t-SNE based on the outputted representations. It is shown that the
five diseases are separated quite well and suggests that MetaPred
generates meaningful representations for patients in several rele-
vant domains.
5 RELATEDWORK
Meta-learning, also known as learning to learn [1, 27, 40], aims
to solve a learning problem in the target task by leveraging the
learning experience from a set of related tasks. Meta-learning al-
gorithms deal with the problem of efficient learning so that they
can learn new concepts or skills fast with just a few seen exam-
ples. Meta-learning algorithms have been recently explored on a
series of topics including few-shot learning [32, 34, 42], reinforce-
ment learning [15, 33] and imitation learning [16]. One scheme of
meta-learning is to incorporate learning structures of data points by
distance functions [26] or embedding networks [36, 42] such that
the classifier can adapt to accommodate unseen tasks in training.
Another scheme is basically optimization-based which is training a
gradient procedure and applied it on a learner directly [1, 15, 32, 34].
Both of the schemes could be summarized as the design and opti-
mization of a function f which gives predictions for the unseen
testing data Xtest with training episodes Depi and parameter col-
lection Θ. Specifically, model-agnostic meta-learning [15] aims to
learn a good parameter initialization for the fast adaptation of test-
ing tasks. It has gained successes in applications such as robotic
[9, 16] and neural machine translation [17].
However, the application of meta-learning in healthcare has
rarely been explored, despite the fact that most of the medical
problems are resource-limited. Consequently, we propose MetaPred
to address the general problem of clinical risk predictions with low-
resource EHRs.
6 CONCLUSION
In this paper, we propose an effective framework MetaPred that
can solve the low-resource medical records problem in clinical
risk prediction. MetaPred leverages deep predictive modeling with
the model agnostic meta-learning to exploit the labeled medical
records from high-resource domain. For the purpose of designing
a more transferable learning procedure, we introduce a objective-
level adaptation for MetaPredwhich not only take advantage of fast
adaptation from optimization-level but also take the supervision
of the high-resources domain into account. Extensive evaluation
involving 5 cognitive diseases is conducted on real-world EHR data
for risk prediction tasks under various source/target combinations.
Our results demonstrated the superior performance of MetaPred
with limited patient EHRs, which can even beat fully supervised
deep neural networks for the challenging risk prediction tasks of
MCI and Alzheimer. For future clinical study, comprehensive lon-
gitudinal records more than 5 years will be explored for cognition
related disorders.
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